ArticleJournal of medicinal chemistry2022

Macrocyclization of Quinazoline-Based EGFR Inhibitors Leads to Exclusive Mutant Selectivity for EGFR L858R and Del19.

Jennifer A Amrhein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.